• Secure Innovation: How Life Sciences and Pharmaceutical Companies Can Safely Seize Opportunity

  • By: Industry Dive's studioID
  • Podcast

Secure Innovation: How Life Sciences and Pharmaceutical Companies Can Safely Seize Opportunity

By: Industry Dive's studioID
  • Summary

  • The life sciences and pharmaceutical sector is constantly evolving and for companies to innovate and stay ahead of the curve, they need to be ready to capitalize on opportunities. Yet, success in life sciences hinges on safely seizing these chances amid inherent risks. Join experts from NTT DATA as they discuss the complex challenges and solutions to maintaining safety and security in cybersecurity, quality assurance & regulatory compliance.
    Copyright Industry Dive's studioID
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Secure your Supply Chain with AI-Enabled Digital Twins
    Dec 20 2023
    In the final episode of Secure Innovation: How Life Sciences and Pharmaceutical Companies Can Safely Seize Opportunity, Pari Sanghavi and Berit Niniass of NTT DATA discuss the importance of preparing for supply chain challenges to ensure your manufacturing operations run smoothly. They discuss the biggest supply chain challenges in life sciences manufacturing, the benefits of digital twins, how you can future-proof your supply chain technology and more. Tune in to learn all about it!
    Show More Show Less
    34 mins
  • Catalyst for Change: New QA Guidelines Create Opportunities for Innovation
    Nov 29 2023
    In the second episode of our three-part podcast series, “Secure Innovation: How Life Sciences Companies Can Safely Seize Opportunity,” we sit down with Robert Willman, Practice Lead for Quality & Regulatory Assurance in the Life Sciences Division at NTT Data, Kevin Thompson, Computer System Validation Manager at NTT Data, and Darren Geaney, Computer Systems Validation Specialist at Kneat Solutions, to discuss quality assurance as an essential part of the safe manufacturing and sale of pharmaceutical products. These experts will touch on new compliance requirements, the differences between risk-based vs. opportunity-based approach to compliance and quality assurance and the benefits of focusing QA efforts on impact to product and patient.
    Show More Show Less
    28 mins
  • 6 Steps to Strong Cybersecurity in Life Sciences Manufacturing
    Oct 25 2023
    In the first episode of our three-part podcast series, “Secure Innovation: How Life Sciences Companies Can Safely Seize Opportunity,” hear from Phani Changanti, head of Cyber Resilience at NTT DATA, on the 6-step roadmap to help life science companies assess and strengthen cybersecurity in life sciences. Learn about the major cybersecurity challenges in life sciences manufacturing, how to assess operational security and the difference between cybersecurity and compliance.
    Show More Show Less
    33 mins

What listeners say about Secure Innovation: How Life Sciences and Pharmaceutical Companies Can Safely Seize Opportunity

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.